U.S. markets closed

Horizon Therapeutics Public Limited Company (HZNP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
93.79+1.65 (+1.79%)
At close: 4:00PM EDT

92.67 -1.12 (-1.19%)
After hours: 4:10PM EDT

Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 5/16/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 1.10
52-Week Change 399.48%
S&P500 52-Week Change 341.30%
52 Week High 397.20
52 Week Low 345.01
50-Day Moving Average 390.91
200-Day Moving Average 382.00

Share Statistics

Avg Vol (3 month) 31.72M
Avg Vol (10 day) 31.33M
Shares Outstanding 5224.77M
Implied Shares Outstanding 6N/A
Float 221.03M
% Held by Insiders 11.35%
% Held by Institutions 191.43%
Shares Short (Apr 29, 2021) 46.04M
Short Ratio (Apr 29, 2021) 44.19
Short % of Float (Apr 29, 2021) 42.77%
Short % of Shares Outstanding (Apr 29, 2021) 42.69%
Shares Short (prior month Mar 30, 2021) 45.77M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 12.80%
Operating Margin (ttm)19.57%

Management Effectiveness

Return on Assets (ttm)4.40%
Return on Equity (ttm)9.27%

Income Statement

Revenue (ttm)2.19B
Revenue Per Share (ttm)10.30
Quarterly Revenue Growth (yoy)-3.80%
Gross Profit (ttm)1.67B
EBITDA 515.86M
Net Income Avi to Common (ttm)280.04M
Diluted EPS (ttm)1.25
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)811.61M
Total Cash Per Share (mrq)3.61
Total Debt (mrq)2.63B
Total Debt/Equity (mrq)68.15
Current Ratio (mrq)2.37
Book Value Per Share (mrq)17.16

Cash Flow Statement

Operating Cash Flow (ttm)614.55M
Levered Free Cash Flow (ttm)381.82M